TNGX - Tango Therapeutics, Inc.

QQQ $ 617.50 $ 6.52 (1.07 %)

DIA $ 472.45 $ 4.92 (1.05 %)

SPY $ 677.25 $ 5.49 (0.82 %)

TLT $ 91.47 $ 0.04 (0.04 %)

GLD $ 378.59 $ -1.27 (-0.34 %)

Previous Close

$ 7.495

Open

$ 7.84

Bid

$ 7.45 x 50

Ask

$ 8.66 x 31

Day's Range

$ 7.48 - $ 8.12

52 Week Range

$ 1.03 - $ 9.70

Volume

6,310,261

Average Volume

Market Cap

833.9M

Beta (5Y Monthly)

$ 1.05

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	02-27-2025	01-01-1970	10-K
4	11-06-2024	09-30-2024	10-Q
5	08-07-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	03-18-2024	12-31-2023	10-K
8	11-08-2023	09-30-2023	10-Q
9	08-07-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	03-27-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-10-2022	06-30-2022	10-Q
14	05-11-2022	03-31-2022	10-Q
15	03-28-2022	12-31-2021	10-K
16	11-09-2021	09-30-2021	10-Q
17	08-09-2021	06-30-2021	10-Q
18	05-14-2021	03-31-2021	10-Q
19	03-31-2021	12-31-2020	10-K
20	11-13-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Guggenheim Maintains Buy on Tango Therapeu...
10/24/2025 12:01:55

Guggenheim analyst Charles Zhu maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price target from $10 to...

tango-therapeutics-touts-encouraging-data-from-early-stage-cancer-trial-raises-capital-to-fund-advancement

Tango Therapeutics Touts Encouraging Data ...
10/23/2025 15:17:16

Tango Therapeutics Inc. (NASDAQ:TNGX) revealed data from its ongoing Phase 1/2 study of vopimetostat (TNG462) in patients with ...

12 Health Care Stocks Moving In Thursday's...
10/23/2025 12:07:49

Tango Therapeutics Announces $225M Financi...
10/23/2025 11:23:38

Tango Therapeutics, Inc. (NASDAQ:TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next...

Tango Therapeutics' New Drug Doubles Respo...
10/23/2025 11:06:08

Tango Therapeutics, Inc. (NASDAQ:TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next...

Tango Therapeutics To Showcase Initial Cli...
10/06/2025 11:09:54

Piper Sandler Initiates Coverage On Tango ...
08/19/2025 11:51:28

Piper Sandler analyst Kelsey Goodwin initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Overweight rating and ann...

Guggenheim Maintains Buy on Tango Therapeu...
08/06/2025 15:00:20

Guggenheim analyst Michael Schmidt maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price target from $8...

Tango Therapeutics Q2 EPS $(0.35) Beats $(...
08/05/2025 11:05:35

Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(...

Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

Tango Therapeutics Doses First Patient In ...
06/27/2025 11:05:38

sarepta-therapeutics-kulr-technology-group-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

Sarepta Therapeutics, KULR Technology Grou...
06/16/2025 12:38:15

quanex-building-products-manchester-united-byrna-technologies-and-other-big-stocks-moving-higher-on-friday

Quanex Building Products, Manchester Unite...
06/06/2025 14:20:02

12 Health Care Stocks Moving In Thursday's...
05/29/2025 21:06:36

Tango Therapeutics Announces First Patient...
05/21/2025 11:15:50

Tango Therapeutics, Inc. (NASDAQ:TNGX), a clinical-stage biotechnology company committed to discovering the next generation of ...

12 Health Care Stocks Moving In Monday's I...
05/19/2025 17:05:59

Tango Therapeutics Q1 EPS $(0.36) Misses $...
05/12/2025 11:03:02

Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of ...

Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31

Insights into Tango Therapeutics's Upcomin...
05/09/2025 20:03:39

HC Wainwright & Co. Reiterates Buy on Tang...
04/14/2025 10:42:25

HC Wainwright & Co. analyst Robert Burns reiterates Tango Therapeutics (NASDAQ:TNGX) with a Buy and maintains $13 price ...